Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Anticancer Research|January 31, 2012
Role of the apoptotic and mitotic regulator survivin in melanomaJodi A McKenzie, Douglas GrossmanCancer Discovery|September 3, 2016
Complementing T-cell Function: An Inhibitory Role of the Complement System in T-cell-Mediated Antitumor ImmunityWeiyi Peng, Jodi A McKenzie, Patrick HwuCancer Research|September 3, 2010
Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulationJodi A McKenzie, Tong Liu, Agnessa G Goodson, et al.Carcinogenesis|May 4, 2013
Survivin promotion of melanoma metastasis requires upregulation of α5 integrinJodi A McKenzie, Tong Liu, Jae Y Jung, et al.International Journal of Cancer|June 9, 2023
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trialSun Young Rha, Toni K Choueiri, Vsevolod B Matveev, et al.Journal for Immunotherapy of Cancer|February 16, 2021
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulatorsJiakai Hou, Yunfei Wang, Leilei Shi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss MelanomaWeiyi Peng, Leila J Williams, Chunyu Xu, et al.Journal of the National Cancer Institute|December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer ImmunotherapyJodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A ExpressionLu Huang, Shruti Malu, Jodi A McKenzie, et al.Pageof 2